Gadolinium Claim Time-Barred By Plaintiff’s Admission To FDA Committee

Mealey's (June 5, 2019, 8:58 AM EDT) -- CLEVELAND — An Ohio federal judge on May 15 dismissed a woman’s gadolinium contrast agent injury lawsuit as time-barred after defendant Bayer Healthcare Pharmaceuticals Inc. turned up the plaintiff’s public testimony that she knew her physical problems were allegedly caused by Magnevist (Lori Combs v. Bayer Healthcare Pharmaceuticals Inc., et al., No. 18-802, N.D. Ohio, Eastern Div., 2019 U.S. Dist. LEXIS 82268)....

Attached Documents

Related Sections